DePuy Synthes Acquires Expanding Innovations to Strengthen Spine Surgery Portfolio
DePuy Synthes, a worldwide leader in orthopaedic technologies and solutions, has announced the acquisition of Expanding Innovations, Inc. (EI), a specialist in expandable implant technology for spine surgery. The acquisition enhances the company’s Spine portfolio and reinforces its presence in the fast-growing expandable interbody cage market.
Expanding Innovations is a commercial-stage medical technology company dedicated to the development and commercialization of expandable implant solutions for spinal procedures. Its proprietary non-screw-based interbody cage technology is designed to help reduce the risk of post-operative cage collapse and vertebral body subsidence, while also improving implant stability and supporting procedural efficiency.
The company’s current product portfolio includes the X-PAC® TLIF Expandable Posterior Cage, X-PAC® LLIF Expandable Lateral Cage System, and X-PAC® N-GAGE Lumbar Plate System. Supported by growing surgeon adoption and positive clinical experience, expanding Innovations is continuing to expand its innovation pipeline with next-generation Transforaminal Lumbar Interbody Fusion (TLIF) and Lateral Lumbar Interbody Fusion (LLIF) cages, improved instrumentation, and future development into Anterior Lumbar Interbody Fusion (ALIF) solutions.
The acquisition will allow Expanding Innovations’ technology to complement the DePuy Synthes TriALTIS™ Spine System and become part of the VELYS™ Enabling Tech portfolio for Spine, providing surgeons and patients with a broader and more integrated range of spinal solutions.
“Expanding Innovations is an exciting addition to DePuy Synthes and furthers our commitment to bringing market-leading solutions across our Spine portfolio,” said Namal Nawana, Worldwide President, DePuy Synthes. “Our current portfolio and EI’s innovation pipeline will strengthen our position in this high growth segment while expanding our ability to deliver meaningful innovation for surgeons and patients.”
© Johnson & Johnson and its affiliates 2026. All rights reserved.



